Skip to main content
Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden flag Sweden · Delayed Price · Currency is SEK
342.60
-0.40 (-0.12%)
At close: Dec 5, 2025

STO:SOBI Revenue

Swedish Orphan Biovitrum AB had revenue of 7.78B SEK in the quarter ending September 30, 2025, with 12.79% growth. This brings the company's revenue in the last twelve months to 27.85B, up 9.50% year-over-year. In the year 2024, Swedish Orphan Biovitrum AB had annual revenue of 26.03B with 17.65% growth.

Revenue (ttm)
27.85B
Revenue Growth
+9.50%
P/S Ratio
4.24
Revenue / Employee
14.74M
Employees
1,806
Market Cap
118.08B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202426.03B3.90B17.65%
Dec 31, 202322.12B3.33B17.74%
Dec 31, 202218.79B3.26B21.00%
Dec 31, 202115.53B268.00M1.76%
Dec 31, 202015.26B1.01B7.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Getinge AB 35.85B
Sectra AB 3.37B
Camurus AB 2.35B
Asker Healthcare Group AB 16.41B
Medicover AB 25.67B
BioArctic AB 1.92B
AddLife AB 10.53B
Elekta AB 17.57B
Revenue Rankings

Swedish Orphan Biovitrum AB News

More News